Genome-related differences to Fe overload between and within rodent species were evaluated in the present study. Male B6C3F, mice, yellow and black C5YSF 1 mice, and Fischer 344 (F344) rats were fed AIN-76A diets containing 35 (control), 1,500, 3,500, 5,000, or 10,000 &mu;g carbonyl Fe/g for 12 wk. No effects on body weight gain were observed in the B6C3F, and black C5YSF, mice, whereas at all doses of Fe above the control, weight gain was reduced in yellow C5YSF 1 mice and F344 rats. At the 10,000 &mu;g Fe/g dose, 9 of 12 rats died, but there was no mortality among the mice. In all animals, there was a dose-related increase in liver nonheme Fe, and the Fe was stored in hepatocytes predominantly in the periportal region. There was significant hypertrophy of the hepatocytes in both B6C3F, mice and F344 rats fed the 10,000 &mu;g Fe/g diet. PCNA assays showed significant stimulatory effects of the high dose of Fe on hepatocyte proliferation in the F344 rats and the C5YSF, mice but not in the B6C3F, mice. In the rat, there was pancreatic atrophy with loss of both endocrine and exocrine tissue. Morphometric evaluation of pancreas showed fewer & b e t a ; cells in B6C3F, and yellow C5YSF 1 mice but not in the black C5YSF 1 mice. There were fewer islets in the yellow C5YSF 1 mice, and total and mean islet areas were smaller than in the control mice. Rats in the 10,000 &mu;g Fe/g dose group had markedly exacerbated dose-dependent nephropathy and changes in glomerular and tubular epithelium associated with Fe accumulation. The rats also showed degeneration of the germinal epithelium of the testis, formation of multinucleated giant cells, and lack of mature sperm.
INTRODUCTION
Genetic hemochromatosis (GH) is an autosomal recessive disorder of Fe metabolism that is one of the most prevalent genetic diseases in humans of Northern European descent. Approximately 1 in 400 individuals are afflicted and estimates reveal that 1 in 10 carry the gene for the disease (6) . The increased intestinal absorption of Fe results in slow progressive accumulation of Fe throughout life (34) . Major complications of GH are diabetes mellitus, cirrhosis of the liver, and congestive heart disease. The disease is also associated with a substantially increased risk of developing hepatocellular carcinoma.
Feder et al (7) recently identified the gene in which the hemochromatosis defect lies. This gene encodes a major histocompatibility complex (MHC) class-I-like protein termed HLA-H. Of the 178 GH patients tested, 147 (83%) were homozygous for this mutation and 8 (4%) were compound heterozygous. Because this protein has not previously been considered in Fe metabolism or absorption, the mechanism by which an HLA-H defect alters Fe metabolism or absorption is still unknown. Feder et al (7) hypothesized that the HLA-H protein may act as a receptor for an Fe-binding ligand that could down-regulate Fe absorption from the enterocyte to the plasma. It was also suggested that HLA-H protein could be a sensor for plasma Fe levels and regulate the appropriate genes or gene products that control the rate of Fe transfer; or it could act indirectly through association with components of the immune system to regulate Fe metabolism. HLA-H mRNA is found in a wide variety of tissues suggesting that the defect may not be limited to the intestinal mucosa.
In the liver of GH patients, Fe is initially deposited in the periportal hepatocytes as granules of hemosiderin, with little Fe deposited in the Kupffer cells. Hemosiderosis occurs with the progression of Fe accumulation in the liver and leads to fibrosis, micronodular cirrhosis, and hepatocellular carcinoma. Approximately 30% of patients with liver cirrhosis develop hepatocellular carcinoma. It is a late complication and the frequency is about 200 times that in the general population (18) .
Diabetes mellitus is a common finding in patients with GH. In 1935 Sheldon (23) initially recorded that of 311 1 patients with hemochromatosis, 242 had clinical diabetes (78%) and most died from diabetic coma shortly after diagnosis. Since that time other investigators have reported similar frequencies. Dymock and coworkers (5) reported that clinical diabetes developed in 72 of 115 patients with GH and that symptoms of diabetes preceded other manifestations of GH in 74 (65%) of these patients.
The symptoms were no different from those observed in diabetes mellitus, the most common being polyuria, polydipsia, and rapid weight loss. In a more recent study of 163 patients with GH, 115 patients with liver cirrhosis (71 %) had diabetes mellitus, whereas only 20% of noncirrhotic patients were diabetic (18) . In the 251 patients diagnosed with hemochromatosis at the University of Dusseldorf from 1959-1992, 120 (48%) showed symptoms of diabetes mellitus (19) . Niederau et al (19) subsequently reported that diabetes mellitus correlated with the amount of mobilizable Fe. Phatak and Cappuccio (21) reported that patients with GH-induced diabetes can have symptoms varying from mild glucose intolerance to insulin-dependent diabetes with associated systemic complications. Patients with GH may also have both insulin resistance and impaired insulin secretion (27) . Extensive hemosiderin deposits were usually present in the pancreatic interstitium and islet P cells, and fibrosis was commonly observed in the pancreas. Iron was deposited in the exocrine cells, but no effects on exocrine pancreatic function have been reported. The islets were of normal size and shape, unlike those found in type I diabetes, and did not exhibit the amyloid of type II diabetes (22) . Megyesi and coworkers (16) attributed the insulin resistance to excessive amounts of Fe in the hepatocytes or the presence of cirrhosis.
Cardiac manifestations are common in GH unless the Fe is removed. Arrhythmias or cardiac failure develop in more than one-third of untreated cases; the average age of onset is 56 yr (17) . At autopsy the weight of the heart is usually 2-3 times the normal rate. Hemosiderin is present in both interstitial cells and myocardial fibers. Buja and Roberts (4) describe degeneration, fragmentation, and necrosis of myocardial cells with fibrosis and interstitial edema.
In this study,5 the genome-related differences in response to various dietary levels of Fe were compared in the Fischer 344 (F344) rat, B6C3F, mouse, and CSYSF, ¡ mouse, which consists of two distinct genotypes, obese yellow Alyla and lean black ala. The range of toxic responses exhibited in these models should enable selection of a relevant animal model or models to study further the mechanisms underlying the diverse effects of Fe overload.
MATERIALS AND METHODS
Animals and Diets. Weanling male F, hybrid mice from the following two crosses were used: C5YSF,-yellow (AvY/a) + C5YSF,-black (ala) Beginning at 5 wk of age, groups of 12 male mice of each F, genotype and groups of 12 male F344 rats were housed in polycarbonate cages, 4/cage for mice and 2/cage for rats, and maintained in a temperature-and light-controlled environment. The animals were initially divided into 5 groups of approximately equal mean body weight and were given free access to food and distilled, deionized water for 12 wk. Carbonyl Fe (ISP Technologies, Inc., Wayne, NJ) was incorporated into the AIN-76A diet (Dyets, Inc., Bethlehem, PA), which contained Table I .
At the end of the 12-wk feeding period, the animals were fasted for approximately 15 hr. A complete necropsy was performed on each animal and tissues were fixed in 10% neutral buffered formalin. Tissue specimens were then trimmed, processed through an ascending ethanol series and xylene, embedded in paraffin, and sectioned at 5 [Lm. One set of tissues was stained with hematoxylin and eosin (H&E).
Another set of the pancreas, liver, spleen, kidney, and heart was reacted with Perl's Prussian blue for Fe, which involves colorless potassium ferrocyanide reacting with ferric ions to create an insoluble blue ferric ferrocyanide (15, 30) . Nonheme Iron. Nonheme Fe was determined in livers by the bathophenanthroline reaction and expressed as [Lg Fe/g liver. Approximately 1 g of each previously blotted liver was weighed and placed in a 50-ml polypropylene centrifuge tube, and distilled, deionized water was added to bring the volume to 15 ml. The tissue was then homogenized for 30 sec with a Polytron. A 3-ml sample of the homogenate was transferred to another 50-ml centrifuge tube, and 10 ml of acid reagent was added (6 M HCI and 1.2 M trichloroacetic acid, l:l, v/v) and mixed well.
This mixture was then heated in an oven at 65°C for 20 hr, cooled, and centrifuged at 1,500 X g for 20 min. Duplicate 0.2-ml aliquots of the supernatant fraction were pipetted into small polypropylene tubes, and 1.8 ml of freshly prepared color reagent was added, mixed, and incubated for 10 min at room temperature. Absorbance was a Values are the mean ± SEM: n = 12 mice/treatment group. Means for a variable not sharing a common symbol (*, t, $, §, #) are significantly different (p < 0.05) as determined by the Duncan multiple comparison method, which was applied only if significant differences were determined to exist by ANOVA. determined spectrophotometrically at 535 nm, and Fe concentration (Rg Fe/ml) was determined by reference to a standard curve. The bathophenanthroline color reagent (which was protected from light) was prepared by dissolving 62.5 mg bathophenanthroline disulfonic acid and 0.25 ml thioglycolic acid in distilled, deionized water and diluting to 25 ml. The final color reagent was a solution of the bathophenanthroline color reagent, saturated sodium acetate (4.5 M), and distilled, deionized water (1: 20:20 by volume). Immunohistochemical Assays. Cell proliferation indices in the livers were determined by immunohistochemical localization of proliferating cell nuclear antigen (PCNA), slightly modified from Foley et al (8) . Formalinfixed tissues were embedded in paraffin and 5-jjLm-thick sections were deparaffinized in xylene and rehydrated with decreasing concentrations of ethanol into phosphatebuffered saline. Endogenous peroxidase was quenched with 3% H202 containing 0.1 % sodium azide. The sections were placed in an antigen-retrieval solution consisting of 1 °~o zinc sulfate in deionized water and heated for 7.5 min in a 700-watt microwave oven on full power. A routine streptavidin procedure was performed, beginning with application of 0.5% casein to block nonspecific binding of subsequent antibody and sequential incubation of the sections in a mouse monoclonal anti-PCNA antibody (clone PC 10, Dako Corp., Carpinteria, CA), biotinylated goat anti-mouse IgG f(ab)2 (Boehringer-Mannheim, Indianapolis, IN), and streptavidin-conjugated horseradish peroxidase (Jackson Immunoresearch Laboratories, Inc., West Grove, PA). The PCNA-positive cells were visualized by incubating the sections in 3,3'-diaminobenzidine hydrochloride (DAB) chromogen followed by counterstaining with Mayer's hematoxylin (8) .
Differential effects of Fe on the pancreas were assessed by immunohistochemical identification and determination of the numbers of a, )3, and 8 cells in the islets of Langerhans in the untreated control groups and in the 10,000 jig Fe/g groups for mice and 5,000 jjbg Fe/g group for rats. Pancreas Nforphometry. To ensure uniform diameter of sections of equivalent area, pancreatic tissues were adhered to filter paper and fixed in 10% neutral buffered formalin. Procedures for embedding, sectioning, staining, and evaluating the pancreas were standardized to assure uniformity. Five-micron sections were mounted on positively charged slides and immunostained by using the StreptAvidin peroxidase detection system with DAB (3,3'-diaminobenzidine) as the chromogen substrate and Mayer's hematoxylin as the counterstain. Sections were incubated with a polyclonal antibody to insulin (1:600 dilution) (Dako Corp.). Cells were counted and areas measured by using the Optimas Image Analysis System (Optimas Corp., Edmonds, WA). All islets present in a representative section of each pancreas were evaluated for (3 cell number and islet area. Statistical Analysis. Differences among dietary treatment groups were assessed by 1-way analysis of variance (ANOVA), using the ABstat (2) general linear model program. The Duncan multiple comparison method was used to differentiate among means for variables that were significantly affected by the treatments (26) . Values are expressed as meant-SEM. Correlation coefficients were determined by using Pearson's product moment correlation matrix (26) . Mean organ: brain weight ratios were compared by 2-sided Student's t-tests. Immunohistochemical assays and pancreas morphometry data were compared by ANOVA with the Holm's correction (11) .
RESULTS

Body Weight
The 10,000 )JLg Fe/g dose exerted no inhibitory effect on body weight increase in the B6C3F, (Table II) and black CSYSF, (Table III) mice, but a marked inhibitory effect on body weight among the yellow CSYSF, mice (Table IV) . There was decreased food intake in the B6C3F, and yellow CSYSF,. In contrast, food intake by black C5YSF, mice was not affected by supplemental Fe. Among the F344 rats, body weight decreased in a dose-dependent manner. In the 10,000 Rg Fe/g group, death occurred in 9 of 12 rats before the end of the 90day treatment period (Table V) .
Liver
After feeding animals with the 5 doses of carbonyl Fe for 12 wk, a dose-related increase in liver nonheme Fe was observed (Tables II-V) . Histopathologic examination of liver sections of animals at the high Fe dose level subjected to the Prussian blue reaction revealed the presence of intensely blue-stained Fe or hemosiderin (Fig. 1 ). In the livers of yellow and black C5YSF, mice at the 10,000 [Lg Fe/g dose level, moderate Fe deposition in hepatocytes and Kupffer cells, predominantly in the periportal region, was observed. Bile duct inflammation (6/12) and focal hepatocyte necrosis (2/12) were also seen in the yellow C5YSF, mice fed the 10,000 jjLg Fe/g diet. In the livers of the B6C3F, mice, Fe deposition (average severity score 3.4) was similar to that observed in the mice of the other genotypes. In contrast to both the yellow and black C5YSF, mice, the B6C3F, mice exhib-ited significant hypertrophy of hepatocytes, primarily in the periportal region.
Hemosiderin in the liver of the rats fed the 10,000 jjbg Fe/g diet was primarily in hepatocytes in periportal areas and also in some Kupffer cells and some periportal macrophages (average severity score 3.6) ( Fig. 1 ). In rats fed the 5,000 )JLg Fe/g diet, Fe pigmentation was also demonstrable with an average severity score of 2.1. All rats fed the 10,000 ~g Fe/g diet showed minimal to moderate periportal hepatocyte hypertrophy (average severity score 2.3). This appeared to be associated with marked accumulation of Fe in these cells. Similar hypertrophic changes were not observed in control rats or in rats fed the 5,000 )JLg Fe/g diet.
PCNA assays revealed significant stimulatory effects of the high dose of Fe on hepatocyte proliferation in both black and yellow C5YSF, hybrids and the F344 rats, but not in the B6C3F, mice (Table II) . This effect was greatest in the yellow mice and in the rats. Among the control groups, both yellow CSYSF, mice and F344 rats exhib-TABLE IV.-Effect of feeding carbonyl Fe for 90 days on C5YSF,-yellow (AI'lla) male mice.a I Values are the mean ± SEM; n = 12 mice/treatment group. Means for a variable not sharing a common symbol (*, t, t, §) are significantly different (p < 0.05) as determined by the Duncan multiple comparison method, which was applied only if significant differences were determined to exist by ANOVA. a Values are the mean ::I: SEM; n = 12 rats/treatment group except for the group receiving 10,000 vg Fe/g diet (n = 3). Means for a variable not sharing a common symbol (*, fi, t, §) are significantly different (p < 0.05) as determined by the Duncan multiple comparison method, which was applied only if significant differences were determined to exist by ANOVA. ited greater proliferative activity than either the black C5YSF, mice or the B6C3F, mice.
Pancreas
The pancreatic acinar cells of the B6C3F, mice at the 10,000 >g Fe/g dose level had an increased content of apical secretory granules (cytoplasmic alteration). In contrast, the pancreas of both the yellow and black CSYSF, ¡ hybrids appeared to be unaffected histologically by the Fe treatment.
The pancreas in rats fed 10,000 )JLg Fe/g had moderate to severe parenchymal degeneration (average severity score 3.7) characterized by loss of acinar cells and islets, fat infiltration, proliferation of oval cells with formation of ductular profiles, and an absence of inflammatory changes. Islet cells appeared to persist longer than acinar cells, and acinar cells appeared to die by apoptosis. Apoptotic cells were recognized by typical morphologic features, including condensed, sometimes fragmented, hyperchromatic nuclei and shrunken eosinophilic cytoplasm. Similar but less severe changes were seen in the pancreas of rats fed 5,000 ~g Fe/kg (average severity score 2.8). In the most severely affected animals more than 75% of acinar cells were replaced by adipose tissue.
There were islets, small groups of islet cells, and even individual islet cells scattered among adipose cells or within clusters of acinar cells (Fig. 2 ). Early fibroplasia surrounded many exocrine ducts, some of which were hyperplastic. Minimal amounts of Fe were observed in acinar cells of rats at both the 10,000 and 5,000 Rg Fe/g dose levels. At the 3,500 Rg Fe/g dose level, apoptosis and fatty replacement of pancreatic acinar cells were evident in all rats, but in minimal to moderate degree (Fig.  3 ). In the 1,500 )JLg Fe/g group, 7 of 12 rats had minimal to mild loss of acinar cells, early ductal hyperplasia and minimal to mild replacement by fat. The remaining 5 animals in this group had no secondary changes, but mild to marked apoptosis of acinar cells was present.
Islets and a, (3, and 8 Cells
The number of (3 cells in the pancreatic islets was decreased in both B6C3F, and yellow C5YSF, mice at the 10,000 ~g Fe/g dose level, whereas no effect was observed in the black CSY~F, mice. In the B6C3F, mice the number of 8 cells was decreased at the 10,000 j.1g
Fe/g dose level, but there was no effect on Among the yellow C5YSF, mice at the 10,000 )JLg Fe/g dose level, fewer islets were present, and total and mean islet areas were smaller than in the control mice. However, islet numbers and mean and total islet areas were similar in all black C5YSF, and B6C3F, mice.
Because of the distorted structure of the islets in rats fed the 5,000 )JLg Fe/g diet (Fig. 4) , islet area and number were quantified in rats fed the diet containing 3,500 Rg Fe/g. At this dose level, an increase in number of a, [3, and 8 cells was observed, as was an increase in the number of islets, resulting in an increase in the total islet area.
Because of this increase in the number of islets, there was a decrease in the mean islet area.
Spleen
The spleen: brain weight ratios differed significantly between the 10,000 jig Fe/g and control groups of both C5YSF, genotypes, but not among the B6C3F, mice. Increased spleen weights in the mice were due to expansion of the red pulp through increased hematopoiesis and a larger number of Fe-containing macrophages. Extramedullary hematopoiesis was characterized by sharply increased numbers of megakaryocytes, unidentifiable blood stem cells, and immature stages of both leukocytes and erythrocytes. Residual blood trapped in the red pulp at necropsy also contributed to spleen weight; this appeared to be proportionally greater in the high dose mice. Iron uptake in spleens of B6C3F, mice was greater than that in C5YSF, mice, both in the control and 10,000 Rg Fe/g groups.
Rats in the 10,000 )JLg Fe/g dose group had marked lymphocyte depletion in the spleen (average severity score 4.0). This depletion involved both periarteriolar lymphoid sheaths and marginal zones, but marginal zones were more severely affected than periarteriolar lymphoid sheaths. Lymphocyte depletion was also observed in rats fed 5,000 ~g Fe/g, but the lesion was not as severe (average severity score 2.0). There appeared to be no difference in the extent or distribution of Fe deposits in macrophages of rats fed diets containing 35 or 10,000 Rg Fe/g.
Heart
The heart: brain weight ratios were increased in all mouse genotypes as well as in the rats at the 10,000 [Lg Fe/g dose level, but the ratio increases were proportionally less in the rats than in the mice. Hearts of the yellow C5YSF, mice in the 10,000 (Jbg Fe/g group were larger than those in the comparable black C5YSF, mice.
Microscopic examination failed to reveal the basis for the increased heart weights. Any increase in myocyte volume or number was not detectable by routine microscopy.
The hearts may have been more flaccid because of treatment and may have retained, as a consequence, more blood in their vessels and chambers, thus increasing their weight. They did not appear to be congested. In the rats, cardiomyopathy occurred more frequently in control animals (10/12 rats, with an average severity grade of 1.1) than in rats fed 5,000 ~,g Fe/g (3/12 rats, average severity grade of 1.0). Of the 12 hearts examined from rats fed 10,000 jjbg Fe/g, cardiomyopathy (severity grade 1.0) was observed on H&E-stained sections in only 1 animal. Kidney B6C3F, mice in the 10,000 )JLg Fe/g group exhibited some Fe deposition in the epithelium of the proximal tubules. Mild proliferation of mesangial and/or glomerular epithelial cells was also observed. No explanation for the slight decreases in mouse kidney weights was evident microscopically.
Kidney degeneration (nephropathy) occurs as an aging change in F344 rats. The severity in control animals was minimal, but all rats in the group were affected (average severity score of 1.0) (Fig. 5 ). In contrast, there was marked nephropathy in rats fed 10,000 jjbg Fe/g, all of which were affected (average severity score of 4.0). Early death in 9 of the 12 rats fed 10,000 )JLg Fe/g was attributed to this severe nephropathy. All rats fed 5,000 pg Fe/g also had an increased severity of nephropathy (average severity score of 1.9). Perl's staining of kidney sections from the 3 rats fed the 10,000 fJLg Fe/g diet that survived until sacrifice revealed Fe granules in glomerular and tubular epithelium. The extent of Fe deposition varied among animals and the average severity score was 2.0.
Other Lesions
Other lesions observed in F344 rats fed 10,000 )JLg Fe/g included degeneration of the germinal epithelium of the testis (9/9 affected, average severity score 2.7) ( Fig. 6) , lymphocyte depletion and histiocytic cell infiltration in the mesenteric lymph nodes, and thymic atrophy. In rats that died, thymuses could not be identified grossly, and thymic weights in sacrificed rats were very low.
DISCUSSION
Genome-related differences in response to toxic conditions or toxicants are an important aspect in choosing an animal model for investigation of the physiologic, cellular, and molecular mechanisms underlying the particular responses. These differences in response to a 12-wk exposure to Fe overload, both between and within species, were observed in the present study. Of the genotypes used, F344 rats were the most sensitive to the toxic effects of the Fe. At the 10,000 )JLg Fe/g dose, 9 out of 12 rats died, and weight gain was reduced at all levels of Fe greater than control. In contrast, no mice of either F, hybrid in the 10,000 >g Fe/g dose group died, and weight gain was significantly reduced in the 10,000 J.Lg Fe/g dose group only in the obese yellow C5YSF, animals when compared to the control group.
In all animals, there was a dose-related increase in liver nonheme Fe. In the B6C3F, mice and F344 rats fed the 10,000 )JLg Fe/g diet, hepatocellular hypertrophy located predominantly in the periportal region (Zone 1) of the liver lobules was also observed. PCNA assays revealed significant stimulatory effects of the high dose of Fe on hepatocyte proliferation in F344 rats and in both black and yellow C5YSF, mice, but not in the B6C3F, mice. It has recently been reported (25) that a carbonyl Fe-supplemented diet induced extensive oval cell proliferation in the livers of Wistar rats. However, no changes of this type were observed in this study. In the human with GH, Fe is initially deposited in the liver in the periportal hepatocytes. In advanced stages of Fe overload, Fe accumulates in midzonal and centrilobular hepatocytes as well as in Kupffer cells. Progression of Fe accumulation in the liver leads to fibrosis, micronodular cirrhosis, and hepatocellular carcinoma. A possible mechanism for liver damage from chronic Fe overload may be the effect of free radical formation and lipid peroxidation. Whittaker et al (32, 35) previously reported that liver lipid peroxides were significantly increased in Fe-overloaded rats. Lipid peroxidation is a chain reaction that is increased by iron and may have pathophysiologic consequences in diseases such as atherosclerosis, cancer, and iron overload. The superoxide radical in the presence of Fe3+ and hydrogen peroxide can produce the hydroxyl radical by the Haber-Weiss reaction. The hydroxyl radical, in turn, can attack biologic macromolecules and initiate lipid peroxidation, cause depolymerization of polysaccharides and DNA strand breaks, and inactivate enzymes. The presence of superoxide radical and redox-active iron is devastating to the cell in terms of maintaining membrane structure and function, and therefore, viability.
In the F344 rats, Fe induced significant changes in the pancreas. The changes observed in the rats fed the 10,000 (Jbg Fe/g diet were characterized by loss of acinar cells and islets, fat infiltration, proliferation of ductular profiles, and an absence of inflammatory changes. Acinar cells appeared to die by apoptosis, and islet cells appeared to persist longer than acinar cells. Although there was no mortality among the F344 rats at the 5,000 >g Fe/g dose level, most of the acinar pancreatic tissue could not be found by microscopic examination at time of necropsy. The rat may be a good model for diabetes mellitus pathogenesis. The acinar cells of the B6C3F, mice at the 10,000 ~g Fe/g dose level had an increased content of apical secretory granules. The pancreas of both the yellow and black CSYSF, hybrids appeared to be unaffected histologically by the Fe treatment.
In the yellow C5YSF, mice receiving the 10,000 >g Fe/g diet, the number of [3 cells was significantly decreased, as were the number of islets and the mean and total islet areas. In the B6C3F, mice the number of (3 and 8 cells was also reduced. The precise pathogenesis of injury to [3 cells in the human is uncertain, but Shirasuga has shown that diabetic Fe-laden rats regain normal {3 cell ultrastructure after repeated venesection (24) . In contrast, no effects on numbers of a, ~3, or 8 cells, or on islet number or area were observed in the pancreas of black C5YSF, mice; apparently these mice were very resistant to effects of Fe overload, even at the highest dose level. Thus, the F344 rats and the yellow C5YSF, mice exhibited severe pancreatic toxicity due to Fe overload, less severe toxicity occurred in B6C3F, mice, and no toxicity was exhibited by the black C5YSF, mice.
In a previous study Whittaker et al (33) reported the presence of pancreatic atrophy in Sprague-Dawley rats receiving 3,500 and 20,000 [Lg/g diet for 12 wk. This atrophy was associated with extensive loss of both en-docrine and exocrine pancreatic tissue and deposition of Fe-positive material in the stromal or supportive connective tissue and in some pancreatic acinar cells. In studies previously reported for rats fed carbonyl Fe for longer periods of time, no pancreatic atrophy was observed on histologic examination (12, 13, 20) . Although the effect of Fe overload on pancreatic islet cells has been documented in humans, there are fewer reports of its effect on pancreatic exocrine cells. The pathogenic factors in the development of diabetes mellitus in patients with GH include impaired insulin secretion caused by the selective deposition of Fe in 13 cells of the pancreas and insulin resistance due to Fe accumulation in the liver (27) . Stremmel et al (28) also reported that depletion of body Fe stores by phlebotomy treatment results in a lower rate of insulin-dependent diabetes and improves carbohydrate metabolism in about one-half of the patients with noninsulin-dependent diabetes. It has also been reported (22, 29) that Fe accumulates in acinar cells of humans with GH and in patients who receive multiple transfusions. In these patients atrophy of acinar tissue with fibrosis and formation of micronodules was observed. In later stages of GH, a and 13 cells may be diminished in number as the fibrosis increases (3). Decrements in pancreatic exocrine function have also been associated with Fe overload (10, 14) .
The mechanism of acinar cell death in Fe overload has not been established. Absence of necrosis and acute inflammation mitigates against activation of proteolytic enzymes as the cause. Instead, the evidence suggests that activation of the apoptosis program is the probable pathway. Because Fe overload can lead to generation of excess free radicals, these ions may well trigger the apoptotic pathway in this instance. The pathogenetic sequence of acinar cell apoptosis followed by duct cell (and islet cell) hyperplasia with adipocyte accumulation and fibrosis is also produced by ligation of pancreatic ducts in the mouse (1, 31) , opossum, and rat (9) . In the opossum, unlike the rodents, acinar cell loss by apoptosis was less than that caused by ischemic necrosis. The opossum not withstanding, apoptosis appears to represent a &dquo;final common pathways&dquo; to acinar cell depletion under a variety of circumstances stressful to the cells.
The dramatic loss of pancreatic acinar cells probably is not a limiting biological factor of Fe overload because of the abundant reserve capacity of the exocrine pancreas. Idiopathic atrophy and fibrosis of the exocrine pancreas is common in aging animals and humans, and functional deficit occurs only after loss of 90-95% of the cells. Ironinduced injury to myocardium and possibly to pancreatic (3 cells poses the greater threat to well-being.
In the present study, the marginal zone of the splenic white pulp was markedly reduced in F344 rats fed diets containing 10,000 )JLg Fe/g. This reduction in size of the marginal zone may have resulted from atrophy of marginal zone lymphocytes or a lack of their proper development as reported previously by Whittaker et al (33) in Sprague-Dawley rats.
Diminished sexual function is a frequent finding in GH. Loss of libido, testicular atrophy, impotence, and sparse body hair are common. The hypogonadism is due to gonadotropin deficiency. Low responses to gonadotropin-releasing hormone suggest that the lesion is at the pituitary level, although there is also evidence suggesting hypothalamic dysfunction. A consistent lesion observed in the F344 rat fed 10,000 )JLg Fe/g was degeneration of the germinal epithelium of the testis, formation of multinucleated giant cells, and lack of mature sperm.
Kidney degeneration (nephropathy) occurs as an aging change in F344 rats. The severity of this lesion in control animals was minimal; all rats were affected with an average severity score of 1.0. In contrast, there was marked nephropathy in rats fed 10,000 )JLg Fe/g; all animals at this dose were affected (average severity score of 4.0). In addition, rats fed 5,000 ~g Fe/g also had an increased severity of nephropathy (average severity score of 1.9). Thus, Fe administration markedly exacerbated nephropathy in a dose-dependent manner, and changes in glomerular and tubular epithelium were associated with Fe accumulation. This severe nephropathy could have contributed to early death in 9 of the 12 rats fed the 10,000 Rg Fe/g diet.
